Propanc Biopharma, Inc. OTC:PPCB

Propanc Biopharma stock price today

$4.13
+4.12
+2064650%
Financial Health
0
1
2
3
4
5
6
7
8
9

Propanc Biopharma stock price monthly change

-100.00%
month

Propanc Biopharma stock price quarterly change

-100.00%
quarter

Propanc Biopharma stock price yearly change

-100.00%
year

Propanc Biopharma key metrics

Market Cap
355.89K
Enterprise value
1.14M
P/E
-0.05
EV/Sales
N/A
EV/EBITDA
-0.60
Price/Sales
N/A
Price/Book
-0.16
PEG ratio
N/A
EPS
-7.59
Revenue
N/A
EBITDA
-1.59M
Income
-2.98M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Propanc Biopharma stock price history

Propanc Biopharma stock forecast

Propanc Biopharma financial statements

Propanc Biopharma, Inc. (OTC:PPCB): Profit margin
Jun 2022 0 -904.76K
Mar 2023 0 -809.80K
Jun 2023 0 -748.04K
Mar 2024 0 -526.7K
0%
Yield TTM
Propanc Biopharma, Inc. (OTC:PPCB): Payout ratio
Payout ratio 0%
Propanc Biopharma, Inc. (OTC:PPCB): Dividend Yield
2020
2021 249.86%
2022 278.97%
2023 198.64%
2024
Propanc Biopharma, Inc. (OTC:PPCB): Debt to assets
Dec 2022 108022 3.02M 2798.91%
Mar 2023 143742 3.08M 2146.31%
Jun 2023 60328 3.17M 5267.05%
Mar 2024 37337 3.73M 10008.45%
Propanc Biopharma, Inc. (OTC:PPCB): Cash Flow
Jun 2022 -410.99K 0 374.28K
Mar 2023 -192.73K 0 269.5K
Jun 2023 -177.97K 0 100K
Mar 2024 -106.22K 0 70.26K

Propanc Biopharma alternative data

Propanc Biopharma, Inc. (OTC:PPCB): Employee count
Sep 2023 1
Oct 2023 1
Nov 2023 1
Dec 2023 1
Jan 2024 1
Feb 2024 1
Mar 2024 1
Apr 2024 1
May 2024 1
Jun 2024 1
Jul 2024 1

Propanc Biopharma other data

Propanc Biopharma, Inc. (OTC:PPCB): Insider trades (number of shares)
Period Buy Sel
Aug 2012 250000 0
Sep 2012 0 255000
Dec 2012 0 5500
Jan 2013 0 15000
Jul 2013 0 55000
Transaction Date Insider Security Shares Price per share Total value Source
Sale
NATHANIELSZ JAMES ANDREW director, 10 perc.. Common stock, par value $0.001 per share 55,000 $0.09 $5,005
Sale
NATHANIELSZ JAMES ANDREW director, 10 perc.. Common stock, par value $0.001 per share 15,000 $0.2 $3,000
Sale
NATHANIELSZ JAMES ANDREW director, 10 perc.. Common stock, par value $0.001 per share 5,500 $0.2 $1,100
Sale
NATHANIELSZ JAMES ANDREW director, 10 perc.. Common stock, par value $0.001 per share 5,000 $0.2 $1,000
Sale
NATHANIELSZ JAMES ANDREW director, 10 perc.. Common stock, par value $0.001 per share 250,000 $0.2 $50,000
Purchase
NATHANIELSZ JAMES ANDREW director, 10 perc.. Common Stock 250,000 $0.2 $50,000
  • What's the price of Propanc Biopharma stock today?

    One share of Propanc Biopharma stock can currently be purchased for approximately $4.13.

  • When is Propanc Biopharma's next earnings date?

    Unfortunately, Propanc Biopharma's (PPCB) next earnings date is currently unknown.

  • Does Propanc Biopharma pay dividends?

    No, Propanc Biopharma does not pay dividends.

  • How much money does Propanc Biopharma make?

    Propanc Biopharma has a market capitalization of 355.89K.

  • What is Propanc Biopharma's stock symbol?

    Propanc Biopharma, Inc. is traded on the OTC under the ticker symbol "PPCB".

  • What is Propanc Biopharma's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Propanc Biopharma?

    Shares of Propanc Biopharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Propanc Biopharma's key executives?

    Propanc Biopharma's management team includes the following people:

    • Mr. James Nathanielsz Executive Chairman, Chief Executive Officer, Chief Financial Officer, Treasurer & Sec.(age: 51, pay: $541,290)
    • Dr. Julian Norman Kenyon Chief Scientific Officer & Director(age: 77, pay: $40,530)
  • How many employees does Propanc Biopharma have?

    As Jul 2024, Propanc Biopharma employs 1 workers.

  • When Propanc Biopharma went public?

    Propanc Biopharma, Inc. is publicly traded company for more then 12 years since IPO on 12 Nov 2012.

  • What is Propanc Biopharma's official website?

    The official website for Propanc Biopharma is propanc.com.

  • Where are Propanc Biopharma's headquarters?

    Propanc Biopharma is headquartered at 302, 6 Butler Street, Camberwell, VIC.

  • How can i contact Propanc Biopharma?

    Propanc Biopharma's mailing address is 302, 6 Butler Street, Camberwell, VIC and company can be reached via phone at +61 3 9882 0780.

Propanc Biopharma company profile:

Propanc Biopharma, Inc.

propanc.com
Exchange:

OTC

Full time employees:

1

Industry:

Biotechnology

Sector:

Healthcare

Propanc Biopharma, Inc., a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes. The company has a research collaboration with University of Jaén that undertakes the research activities for POP1 joint drug discovery program; and a joint research and drug discovery program with Universities of Jaén and Granada to investigate the changes in genetic and protein expression that occur in cancer cells. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia.

302, 6 Butler Street
Camberwell, VIC 3124

CIK: 0001517681
ISIN: US74346N4043
CUSIP: 74346N404